Signature Equity Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7K Buy
1,961
+90
+5% +$2.05K 0.02% 432
2026
Q1
$40K Buy
1,871
+189
+11% +$3.93K 0.02% 467
2025
Q4
$36K Buy
+1,682
New +$34.5K 0.02% 484

Other funds holding MD

Signature Equity Partners's MD Position: Q2 2026 in Review

Signature Equity Partners increased its Pediatrix Medical (MD) stake by 4.8% in Q2 2026, buying an estimated $2.05K and bringing the position to 1,961 shares worth $49.7K. The position accounts for 0.02% of the portfolio, ranked #432.

Signature Equity Partners first reported a position in MD in Q4 2025 and has held it in 3 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Signature Equity Partners held 1,961 shares of Pediatrix Medical worth $49.7K as of Q2 2026.
  • Signature Equity Partners bought 90 Pediatrix Medical shares in Q2 2026, an estimated $2.05K.
  • Pediatrix Medical made up 0.02% of Signature Equity Partners's portfolio in Q2 2026, its #432 holding.
  • Signature Equity Partners first reported a position in Pediatrix Medical in Q4 2025 and has held it in 3 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.